Download your free ''HTA Process in the UK'' Guide

    Online Health Economic Models with PharmEconix©

    To provide a strong infrastructure for good modeling practice considering:

    1. Clinical realism: A model should reflect the state of evidence, the current understanding of the disease, and be accepted by clinical experts.

    2. Quantifying decision uncertainty: A model should be capable of quantifying decision uncertainty and informing prioritization of future research.

    3. Transparency and reproducibility: Resources should exist so that a model can be completely understood, reproduced, and pressure tested.

    4. Reusability and adaptability: It should be possible to easily update a model to reflect new clinical evidence or adapt it for a new market, indication, or intervention.


    To support our clients for a more efficient introduction of new products to their target groups such as policymakers, clinicians, and patient organizations.

    To provide a quick updating process for the economic model when a new set of input data are available.

    To enhance model adaptation for multiple countries all in one platform. 


    The system consists of two main parts: server-side and client-side. Model engines are developed with the support of R, Python, or Excel on the server-side.

    Depending on the values users submit to the system, the server-side runs the analysis and generates the results. The client-side provides a graphical user interface (GUI) for users to interact with the platform and make appropriate adjustments to the model settings and input values.

    The system has a model administrator to oversee its core-level features. It also supports several user types who can work with the model on the online platform. The main supported user types are local and global team members of the product manufacturers, local policymakers, medical providers, and patient organizations. The model admin can define the level of access given to each user to ensure system security.

    • Different Packages for the Online Model


    We provide strategic planning tools and methods to improve market access, demonstrate the added value of products, and conduct reimbursement assessments.
    Learn More
    A robust marketing strategy when launching new MedTech and Pharma products is essential to achieve optimal market access and product reimbursement.
    Learn More
    We provide structured and targeted literature reviews such as burden of illness, unmet needs assessments, health technology assessment (HTA).
    Learn More
    A well-designed clinical study is central to the appropriate collection of evidence related to a new product, service, or device.
    Learn More
    As a health consultancy company, we are aware of the importance of robust clinical and economic evidence when developing an HTA submission dossier.
    Learn More
    Publishing your research in a high-impact clinical or scientific journal is one of the best and most effective ways of disseminating your findings.
    Learn More

    Have Questions?

    Please complete the form below to contact us for more information